ESR1 and triple-negative breast carcinoma: The molecular classification of BC has been widely studied and commonly grouped into four categories based on hormone receptor expression: estrogen receptor positive (ER+); progesterone receptor positive (PR+); human epidermal growth factor receptor positive (HER2+); and triple-negative breast cancer (TNBC), which is characterized by the lack of expression of any of the mentioned receptors.